Skip to main content
logo
NeoImmuneTech, Inc. (KOSDAQ:950220)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,590.00
+85.00 (3.39%)
Sep 1, 2026, 3:30 PM KST

NeoImmuneTech Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
256,067405,851556,1291,001,0331,974,0795,091,787
Market Cap Growth
-49.56%-27.02%-44.44%-49.29%-61.23%-
Enterprise Value
220,073345,927519,849923,7121,838,8434,930,203
Last Close Price
2590.004105.004672.018409.6216590.8442982.51

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
145.494280.053263.98---
PB Ratio
4.546.8513.3513.3716.4931.42
P/TBV Ratio
7.088.7515.8014.5717.4532.76

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
125.043648.103051.04---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.200.180.260.050.040.04
Net Debt / Equity Ratio
-0.64-0.85-0.57-0.87-0.94-0.92
Net Debt / EBITDA Ratio
1.972.200.641.242.032.97
Net Debt / FCF Ratio
1.522.000.591.292.504.06
Asset Turnover
0.030.000.00---
Quick Ratio
2.682.941.675.367.147.57
Current Ratio
2.833.081.895.617.208.17
Return on Equity (ROE)
-61.03%-63.04%-70.17%-54.90%-42.88%-42.62%
Return on Assets (ROA)
-21.14%-21.48%-32.84%-30.30%-22.25%-22.95%
Return on Capital Employed (ROCE)
-36.40%-41.30%-91.80%-71.90%-47.10%-31.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-9.55%-7.83%-7.35%-5.33%-3.06%-1.03%
FCF Yield
-9.26%-6.19%-7.30%-5.05%-2.27%-0.72%
Buyback Yield / Dilution
-110.94%-19.34%0.24%-0.08%-3.68%-15.27%